| Superdonor FMT in Patients With Ulcerative Colitis (NCT05739864) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2023-02-13 |
| A Study of Tazemetostat in Combination With HMPL-689 in Patients With Relapsed/Refractory Lymphoma (NCT05713110) | Hutchmed | 2023-02-13 |
| Cryotherapy and Intracanal Medicaments for Postoperative Pain in Apical Periodontitis (NCT07437612) | Celalettin Topbaş | 2023-02-13 |
| Neoadjuvant PD-1 Blockade in Resectable Merkel Cell Carcinoma (NCT05496036) | Abramson Cancer Center at Penn Medicine | 2023-02-13 |
| Ph2, Study to Assess the Safety and Efficacy of GPC 100 and Propranolol With and Without G-CSF for the Mobilization of Stem Cells in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant (NCT05561751) | GPCR Therapeutics, Inc. | 2023-02-13 |
| Single Arm Trial of Menstrual Cups Among Economically Vulnerable Women to Reduce Bacterial Vaginosis and STIs (NCT05666778) | Rush University Medical Center | 2023-02-13 |
| Genotype-guided Treatment in Newly Diagnosed PTCL (NCT05675813) | Ruijin Hospital | 2023-02-13 |
| Optimizing and Personalising Azacitidine Combination Therapy for Treating Solid Tumours QPOP and CURATE.AI (NCT05381038) | National University Hospital, Singapore | 2023-02-13 |
| Encorafenib Plus Cetuximab in a Neoadjuvant Setting in Patients With BRAF Mutation Localised Colon or Upper Rectum Cancer (NCT05706779) | Federation Francophone de Cancerologie Digestive | 2023-02-13 |
| Insulin and Abatacept in Recently-diagnosed Type 1 Diabetes (NCT05742243) | Melbourne Health | 2023-02-13 |
| Lowdose Nivolumab in Combination With AVD as Front Line Therapy for Classic Hodgkin's Lymphoma (NCT05772624) | Hospital Universitario Dr. Jose E. Gonzalez | 2023-02-13 |
| Hyperthermic Intraperitoneal Treatment of rmhTNF for CRCPM: Phase II Clinical Trial (NCT05755685) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2023-02-10 |
| A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer (NCT05751434) | City of Hope Medical Center | 2023-02-10 |
| Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer (NCT05739981) | Imunon | 2023-02-10 |
| AK104 in Neoadjuvant Treatment of Cervical Cancer (NCT05227651) | Akeso | 2023-02-10 |
| A Study of GNC-038, a Tetra-specific Antibody, in Patients With Central Nervous System Lymphoma (PCNSL) and Relapsed or Refractory Secondary Central Nervous System Lymphoma (SCNSL) (NCT05485753) | Sichuan Baili Pharmaceutical Co., Ltd. | 2023-02-10 |
| HAIC Plus Systemic Chemotherapy, Lenvatinib and Toripalimab in Advanced ICC (NCT07304388) | Sun Yat-sen University | 2023-02-10 |
| First-line Treatment with RC48 Plus Tislelizumab and S-1(RCTS) in Advanced Gastric Cancer (NCT05586061) | Qilu Hospital of Shandong University | 2023-02-10 |
| Study to Determine the Efficacy&Safety of ARV-1801(ACG-701) for the Treatment of Cystic Fibrosis Pulmonary Exacerbations (NCT05641298) | Aceragen | 2023-02-10 |
| Beta-glucan and Fatigue in HSCT Survivors (NCT05524688) | University of Florida | 2023-02-10 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of CS0159 in Subjects With NASH (NCT05591079) | Cascade Pharmaceuticals, Inc | 2023-02-10 |
| An Open-Label Study to Evaluate the Safety, Tolerability and Pharmacodynamics of BPL-003 in Patients With Treatment Resistant Depression (NCT05660642) | Beckley Psytech Limited | 2023-02-10 |
| A Study of SI-B001+SI-B003± Chemotherapy in Patients With Locally Advanced or Metastatic Head and Neck Squamous Cell Carcinoma (NCT05668858) | Sichuan Baili Pharmaceutical Co., Ltd. | 2023-02-10 |
| Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSIL (NCT05555862) | Frantz Viral Therapeutics, LLC | 2023-02-10 |
| A Study of Brentuximab Vedotin in Combination With Cyclophosphamide, Doxorubicin (Hydroxydaunorubicin), Prednisone (CHP) in Chinese Participants With CD30-Positive (CD30+) Peripheral T-Cell Lymphomas (PTCL) (NCT05673785) | Takeda | 2023-02-10 |
| A Study of ASKG712 in Patients With Neovascular Age-Related Macular Degeneration (NCT05456828) | Visara, Inc. | 2023-02-10 |
| Study of AK119 and AK112 With or Without Chemotherapy for NSCLC Patients (NCT05636267) | Akeso | 2023-02-10 |
| Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility Study (NCT04718792) | Anders Fink-Jensen, MD, DMSci | 2023-02-09 |
| To Evaluate the Efficacy and Safety of Afatinib for Advanced ALTRK-negative ESCC (NCT05818982) | Peking University | 2023-02-09 |
| Theophylline Effects in the Fontan Circulation (NCT05717049) | Oslo University Hospital | 2023-02-09 |
| RIC-NEC Randomized Controlled Trial (NCT05279664) | The Hospital for Sick Children | 2023-02-09 |
| Phase 1b/2 Trial of Ipilimumab, Nivolumab, and Ciforadenant (Adenosine A2a Receptor Antagonist) in First-line Advanced Renal Cell Carcinoma. (NCT05501054) | M.D. Anderson Cancer Center | 2023-02-09 |
| JS004 Combined With Toripalimab and With Standard Chemotherapy Treat Patients With Advanced Lung Cancer (NCT05664971) | Shanghai Junshi Bioscience Co., Ltd. | 2023-02-09 |
| A Safety and Efficacy Study of PVX108 in Children and Adolescents With Peanut Allergy (NCT05621317) | Aravax Pty Ltd | 2023-02-09 |
| Tradipitant for Functional Dyspepsia (NCT05653310) | Xiao Jing (Iris) Wang | 2023-02-09 |
| Study to Assess the Efficacy and Safety of Adjuvant Osimertinib in NSCLC With Uncommon EGFRm (NCT05546866) | AstraZeneca | 2023-02-09 |
| Prevention of Severe Acute Graft-versus-host Disease in Pediatric Patients Using a daGOAT Model (NCT05599256) | Institute of Hematology & Blood Diseases Hospital, China | 2023-02-09 |
| Antitumor Activity of Vactosertib in Combination With Pembrolizumab in Acral and Mucosal Melanoma Patients Progressed From Prior Immune Check Point Inhibitor (NCT05436990) | Yonsei University | 2023-02-09 |
| Mesalazine Oral Suspension in Active Eosinophilic Esophagitis (NCT05488405) | Dr. Falk Pharma GmbH | 2023-02-09 |
| Sintilimab Combined With Modified FLOT Regimen in the Treatment of Metastatic Gastric Cancer (NCT05982301) | Fudan University | 2023-02-09 |
| A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT) (NCT05736419) | Memorial Sloan Kettering Cancer Center | 2023-02-09 |
| A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition (NCT05519475) | Regeneron Pharmaceuticals | 2023-02-09 |
| The Study of CM326 in Adult Subjects With Atopic Dermatitis (NCT05671445) | Keymed Biosciences Co.Ltd | 2023-02-09 |
| Safety and Efficacy Study of An Anti-CD38 Antibody Drug Conjugate in Relapsed or Refractory Multiple Myeloma (NCT05565807) | Zhejiang ACEA Pharmaceutical Co. Ltd. | 2023-02-09 |
| Anti Inflammatory Lipid Mediators in Asthma Lipid Anti-Inflammtory Mediators in Asthma (NCT03762395) | University of Colorado, Denver | 2023-02-08 |
| A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes (NCT05536804) | Eli Lilly and Company | 2023-02-08 |
| Erector Spinae Plane Block for Uncomplicated Renal Colic (NCT05625802) | University of Michigan | 2023-02-08 |
| Phase II Study of SHJ002 Sterile Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye Disease (NCT05486728) | Dreamhawk Vision Biotech, Inc. | 2023-02-08 |
| A Study of RD14-01 in Patients With Advanced Solid Tumors (NCT05748938) | 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | 2023-02-08 |
| Northern Alberta Linac-MR Image-Guided Radiotherapy (Northern LIGHTs-2) (NCT05413473) | AHS Cancer Control Alberta | 2023-02-08 |
| A Dose Escalation/Expansion Study of MDK-703 in Patients With Advanced or Metastatic Solid Tumors (NCT05716295) | Medikine, Inc. | 2023-02-08 |
| A Phase 2 Dose-finding Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis (NCT05699239) | Taisho Pharmaceutical Co., Ltd. | 2023-02-08 |
| The Study of GR1802 in Patients with Chronic Rhinosinusitis with Nasal Polyps (NCT05873803) | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 2023-02-08 |
| BSEP Function Rescue During Childhood Inhereditary Cholestatic Diseases (NCT04531878) | Children's Hospital of Fudan University | 2023-02-08 |
| A Trial of Y101D in Combination With Gemcitabine and Albumin Paclitaxel in Patients With Advanced Pancreatic Cancer (NCT06266143) | Wuhan YZY Biopharma Co., Ltd. | 2023-02-08 |
| A First-in-Human, Phase 1 Study of TST003 in Subjects With Solid Tumors (NCT05731271) | Suzhou Transcenta Therapeutics Co., Ltd. | 2023-02-08 |
| Epinephrine in the Pediatric Intensive Care Unit: A Dose-Effect Trial (NCT05327556) | Boston Children's Hospital | 2023-02-08 |
| Ropeginterferon Alfa 2b for Early MyelofibrosisDIPSS Low/Intermediate-1 Risk Myelofibrosis (NCT05731245) | National Taiwan University Hospital | 2023-02-08 |
| Immunonutrition for Diabetic Foot Ulcers (NCT05281562) | Prisma Health-Midlands | 2023-02-08 |
| Trial to Evaluate Safety and Efficacy of KPI-012 Ophthalmic Solution in Participants With PCED (NCT05727878) | Combangio, Inc | 2023-02-07 |
| Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1) (NCT05085574) | Leidos Life Sciences | 2023-02-07 |
| Olaparib Maintenance Therapy in Metastatic Breast Cancer (NCT05629429) | National Taiwan University Hospital | 2023-02-07 |
| Safety and Efficacy of Anti-GPRC5D CAR-T Cells Therapy in the Treatment of r/r MM (NCT05739188) | 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | 2023-02-07 |
| Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer (NCT05605535) | CanariaBio Inc. | 2023-02-07 |
| Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy (NCT05518578) | Supernus Pharmaceuticals, Inc. | 2023-02-07 |
| Tucidinostat and Nab-paclitaxel in Advanced HR+/HER2- Breast Cancer (NCT05633914) | Hunan Cancer Hospital | 2023-02-07 |
| The Use of Steri3X for Prevention of Post-operative Wound Infections in Cesarean Sections (NCT05392400) | University of Tennessee | 2023-02-07 |
| A Study of CNCT19 Treatment in Children and Adolescent r/r ALL Patients(Pediatric) (NCT05667506) | Juventas Cell Therapy Ltd. | 2023-02-07 |
| Study of ST-1898 in Advanced Renal Cell Carcinoma (NCT06127238) | Beijing Scitech-Mq Pharmaceuticals Limited | 2023-02-07 |
| A Study to Evaluate RO7204239 in Participants With Facioscapulohumeral Muscular Dystrophy (NCT05548556) | Hoffmann-La Roche | 2023-02-07 |
| Yale Steroid Enhanced Versus Exparel Nerveblock TKA Part 2 (NCT05736549) | Yale University | 2023-02-07 |
| Use of Socially Assistive Robots for Long Term Care Older Adults With Cognitive Impairment and Apathy (NCT05178992) | Vanderbilt University | 2023-02-07 |
| Cadonilimab for PD-1/PD-L1 Blockade-refractory, MSI-H/dMMR, Advanced Colorectal Cancer (NCT05426005) | Sun Yat-sen University | 2023-02-07 |
| A Study of Anlotinib Combined With or Without PD-1 Antibody on Unresectable High-grade Chondrosarcoma (NCT05193188) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2023-02-06 |
| A Study of MS-553 in Patients With Relapsed or Refractory B-cell Lymphoma (NCT05720052) | MingSight Pharmaceuticals, Inc | 2023-02-06 |
| Study to Evaluate the Efficacy and Safety of RZ402 in Diabetic Macular Edema (DME) (NCT05712720) | Rezolute | 2023-02-06 |
| Safety and Tolerability of KH631 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD) (NCT05672121) | Chengdu Origen Biotechnology Co., Ltd. | 2023-02-06 |
| ARVAC-A New Recombinant Coronavirus Disease 2019 (COVID-19) Vaccine (NCT05752201) | Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno | 2023-02-06 |
| A Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Subjects With Recurrent GBM (NCT05370508) | SonALAsense, Inc. | 2023-02-06 |
| SCRT Sequential Penpulimab in Combination With CAPEOX in the Neoadjuvant Treatment of MSS Locally Advanced Rectal Cancer (NCT05576480) | Ruijin Hospital | 2023-02-06 |
| A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib (NCT05512208) | University of Oklahoma | 2023-02-06 |
| " Evaluation of Safety and Efficacy of Empagliflozin and Sacubitril/Valsartan for CHF With Reduced Ejection Fraction in ACHD " (NCT05580510) | Instituto Nacional de Cardiologia Ignacio Chavez | 2023-02-06 |
| Canakinumab for the Prevention of Progression to Cancer in Patients With Clonal Cytopenias of Unknown Significance, IMPACT Study (NCT05641831) | Uma Borate | 2023-02-06 |
| Preventive stRategy for IMMU132-relatED AEs in TNBC or Luminal Breast Cancer- PRIMED (NCT05520723) | MedSIR | 2023-02-06 |
| A Multi-Center Study on the Use of Rho-Kinase Inhibitor to Reduce or Prevent PVR in RRD Eyes at High Risk for PVR (NCT05660447) | Wills Eye | 2023-02-06 |
| Study on a Live-attenuated Respiratory Syncytial Virus Vaccine for Assessment of Safety, Transmissibility, and Genetic Stability of the Vaccine Virus Among Close Contacts in Infants and Toddlers 6 to < 24 Months of Age in Puerto Rico (USA) (NCT05687279) | Sanofi Pasteur, a Sanofi Company | 2023-02-06 |
| Neoadjuvant Tislelizumab in Combination With Dasatinib and Quercetin in Resectable HNSCC (COIS-01) (NCT05724329) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2023-02-05 |
| Evaluation of Efficacy of Neem (Azadirachta Indica) Versus Triamcinolone Acetonide in the Treatment of Oral Lichen Planus. (NCT07141446) | Goa Dental College | 2023-02-05 |
| Expression-linked and R-ISS-adapted Stratification for First Line Therapy in Multiple Myeloma Patients (NCT05665140) | University Hopsital Schleswig Holstein Campus Lübeck | 2023-02-03 |
| Kisspeptin Administration Subcutaneously to Patients With IHH (NCT05896293) | Stephanie B. Seminara, MD | 2023-02-03 |
| Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors (NCT04665739) | National Cancer Institute (NCI) | 2023-02-03 |
| Gene Transfer Clinical Trial for Infantile and Late Infantile Krabbe Disease Treated Previously With HSCT (NCT05739643) | Forge Biologics, Inc | 2023-02-03 |
| Study of IMX-110 in Combination With Tislelizumab in Patients With Advanced Solid Tumors (NCT05840835) | Immix Biopharma, Inc. | 2023-02-03 |
| Mirdametinib + BGB-3245 in Advanced Solid Tumors (NCT05580770) | SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany | 2023-02-03 |
| HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes (NCT07546929) | Housey Healthcare ULC | 2023-02-03 |
| HTMC0435 and Temozolomide in Treating Patients With Small Cell Lung Cancer (NCT05728619) | Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. | 2023-02-03 |
| GENERATION HD2. A Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen Compared With Placebo in Participants With Prodromal and Early Manifest Huntington's Disease (NCT05686551) | Hoffmann-La Roche | 2023-02-03 |
| Oral Contraceptives for Treating Premenstrual Dysphoric Disorder in Bipolar Disorder (NCT05098574) | St. Joseph's Healthcare Hamilton | 2023-02-03 |
| A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF) (NCT05592275) | Eli Lilly and Company | 2023-02-03 |
| Elacestrant With/Without Triptorelin in Premenopausal Women With Luminal Breast Cancer (NCT05982093) | SOLTI Breast Cancer Research Group | 2023-02-03 |